Quantcast

Latest Diabetic retinopathy Stories

2014-06-11 04:21:59

TARRYTOWN, N.Y., June 11, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Bayer HealthCare today announced that Bayer HealthCare has submitted an application to the European Medicines Agency (EMA) seeking marketing authorization in the European Union (EU) for EYLEA(®) (aflibercept) Injection for the treatment of macular edema following branch retinal vein occlusion (BRVO). The EMA submission is based on the positive Phase 3 VIBRANT trial, a double-masked,...

2014-06-09 08:29:08

VANCOUVER, June 9, 2014 /PRNewswire/ - iCo Therapeutics Inc. ("iCo" or "the Company") (TSX-V: ICO) (OTCQX: ICOTF) today announced top-line results related to the eight month visual acuity (VA) primary endpoint for subjects enrolled in the Phase 2 iDEAL Study, conducted in collaboration with JDRF, evaluating the efficacy and safety after repeated injections of iCo-007 in patients with Diabetic Macular Edema (DME). Statistical methods employed included both Last Observation Carry...

2014-05-28 16:24:35

Major population study finds vasodilators may raise likelihood of age-related macular degeneration SAN FRANCISCO, May 28, 2014 /PRNewswire-USNewswire/ -- There may be a connection between taking vasodilators and developing early-stage age-related macular degeneration (AMD), the leading cause of vision loss and blindness among Americans who are age 65 and older,[1] according to a study published online in Ophthalmology, the journal of the American Academy of Ophthalmology....

2014-05-28 12:30:11

MORGANTOWN, W.Va., May 28, 2014 /PRNewswire/ -- The Eye Foundation of America announced today that it is working with the Gourami Eye Institute, a fully-equipped eye hospital in Rajahmundry, India (300 miles east of Hyderabad) to provide international learning opportunities for ophthalmology students who have an interest in diabetic retinopathy. The program will provide students hands-on experience performing in-the-field diabetic retinopathy preventative screenings as well as...

2014-05-12 11:53:53

Lunenfeld-Tanenbaum Research Institute Bioengineering a safe treatment for retinopathy, the leading cause of vision loss in Canada A new drug approach has been developed for safer clean-up of deformed blood vessels in the eye by a research team at the Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital in Toronto. The growth of malformed blood vessels that can burst is a leading cause of vision loss in North America. Retinopathy and retina degeneration are associated with...

2014-05-11 23:00:24

RnRMarketResearch.com adds “Diabetic Retinopathy Global Clinical Trials Review, H1, 2014” and “Diabetic Ketoacidosis Global Clinical Trials Review, H1, 2014” to its store. Dallas, Texas (PRWEB) May 11, 2014 Diabetic Ketoacidosis Global Clinical Trials Review, H1, 2014 “Diabetic Ketoacidosis Global Clinical Trials Review, H1, 2014″ provides data on the Diabetic Ketoacidosis clinical trial scenario. This report provides elemental information and data relating to the clinical...

2014-05-07 12:26:55

Roche/Genentech's Avastin Continues to Garner the Greatest Physician-Reported Patient Share in DME Due to Its Low Relative Cost, According to Findings from Decision Resources Group BURLINGTON, Mass., May 7, 2014 /PRNewswire/ -- Decision Resources Group finds that, ahead of the anticipated label expansion of Regeneron's Eylea for diabetic macular edema (DME) in August 2014, over half of surveyed U.S. retinal specialists and general ophthalmologists currently prescribe this anti-vascular...

National Eye Institute Celebrates Healthy Vision Month In May
2014-04-30 11:15:22

Lawrence LeBlond for redOrbit.com - Your Universe Online Each May since 2003 the National Eye Institute (NEI) has been celebrating Healthy Vision Month. As with past years, the Institute makes the case for eye care, stating that an eye examination is just as important as seeing a doctor or nurse for a physical examination. During Healthy Vision Month, NEI – an arm of the National Institutes of Health – empowers Americans to make eye health a top priority and educates them on steps...

2014-04-29 08:38:13

Transitions Optical to Supply Complimentary Eye Health Education Resources to NAHN Nurses Across the Country WASHINGTON, April 29, 2014 /PRNewswire/ -- Transitions Optical, Inc. and the National Association of Hispanic Nurses (NAHN) have announced a national partnership to reach Hispanic communities with eye health information. Transitions Optical has joined NAHN as a Corporate Member and will provide education to NAHN members on the higher risk for eye health issues among Hispanic...

2014-04-28 16:31:52

Learn more during the upcoming ARVO annual meeting GAITHERSBURG, Md., April 28, 2014 /PRNewswire/ -- A rigorous multi-center clinical trial has completed testing over 400 diabetic patients to evaluate the effectiveness of RETeval® based visual electrophysiology in assessing sight threatening diabetic retinopathy (DR) in comparison to the gold standard of dilated seven field stereo fundus photography, double read and adjudicated....


Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.